Harmony Biosciences Holdings, Inc. (HRMY)
28.62
-0.28
(-0.97%)
USD |
NASDAQ |
Mar 03, 11:17
Harmony Biosciences Holdings EPS Diluted (Quarterly) : 0.3831 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Castle Biosciences, Inc. | -0.0795 |
| BioMarin Pharmaceutical, Inc. | -0.2423 |
| Amicus Therapeutics, Inc. | 0.0054 |
| Iovance Biotherapeutics, Inc. | -0.1767 |
| Apellis Pharmaceuticals, Inc. | -0.4654 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 22.49M |
| Revenue (Quarterly) | 243.78M |
| Total Expenses (Quarterly) | 221.29M |
| Enterprise Value | 1.124B |
| Gross Profit Margin (Quarterly) | 69.44% |
| Profit Margin (Quarterly) | 9.22% |
| Earnings Yield | 9.46% |
| Operating Earnings Yield | 12.43% |
| Normalized Earnings Yield | 9.464 |